WestEnd Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3
Closed -$192 61
2018
Q4
$192 Sell
3
-1
-25% -$74 ﹤0.01% 57
2018
Q3
$357 Hold
4
﹤0.01% 53
2018
Q2
$317 Hold
4
﹤0.01% 51
2018
Q1
$356 Sell
4
-369,360
-100% -$35.5M ﹤0.01% 49
2017
Q4
$38.5M Sell
369,364
-2,231
-0.6% -$252K 3.56% 19
2017
Q3
$54.2M Sell
371,595
-42,798
-10% -$5.83M 4.76% 6
2017
Q2
$53.8M Sell
414,393
-33,221
-7% -$4.07M 4.6% 9
2017
Q1
$55.7M Sell
447,614
-109,932
-20% -$13.2M 4.65% 12
2016
Q4
$64.5M Sell
557,546
-82,889
-13% -$9.23M 5.15% 3
2016
Q3
$66.9M Sell
640,435
-290,954
-31% -$31.5M 4.8% 15
2016
Q2
$91.9M Buy
931,389
+2,682
+0.3% +$277K 4.88% 16
2016
Q1
$93M Buy
928,707
+100,128
+12% +$10.3M 4.51% 19
2015
Q4
$99.2M Buy
828,579
+22,204
+3% +$2.57M 4.86% 11
2015
Q3
$87.2M Sell
806,375
-117,218
-13% -$14.5M 4.41% 18
2015
Q2
$107M Sell
923,593
-17,856
-2% -$2.04M 4.95% 12
2015
Q1
$109M Sell
941,449
-109,132
-10% -$13M 4.88% 15
2014
Q4
$118M Sell
1,050,581
-45,861
-4% -$4.84M 5.37% 3
2014
Q3
$104M Sell
1,096,442
-85,909
-7% -$7.75M 5.25% 1
2014
Q2
$102M Sell
1,182,351
-141,833
-11% -$10.8M 4.98% 9
2014
Q1
$92.4M Buy
1,324,184
+477,962
+56% +$37.9M 4.51% 18
2013
Q4
$71.5M Sell
846,222
-331,130
-28% -$26.2M 2.58% 19
2013
Q3
$90.7M Sell
1,177,352
-125,022
-10% -$8.76M 2.97% 19
2013
Q2
$76.2M Buy
+1,302,374
New +$78.4M 2.51% 21

Other funds holding CELG

WestEnd Advisors's CELG Position: Q1 2019 in Review

WestEnd Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 3 shares — an estimated $192 sold.

WestEnd Advisors first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $118M in Q4 2014. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • WestEnd Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • WestEnd Advisors sold 3 Celgene Corp shares in Q1 2019, an estimated $192.
  • WestEnd Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • WestEnd Advisors's Celgene Corp position peaked at $118M in Q4 2014.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on WestEnd Advisors's 13F filing for Q1 2019, filed 3 May 2019.